Dosage guide
Lion's Mane dosage
Lion's Mane dosing: typical range, frequency, half-life, onset, routes. Evidence-tiered.
At a glance
- Typical dose
- 1000mg
- Half-life
- 6hr
- Frequency
- 1 to 2 times daily
- Routes
- oral
Protocol
- 1
Measure the dose
Typical Lion's Mane dose is 1000 mg (500 mg to 3 g/day depending on product form; trial-effective whole-powder doses are 3 g/day). Use a weight-based calculator for individual adjustments.
Open tool → - 2
Set the frequency
Administer 1 to 2 times daily. Half-life of 6 hours anchors the dosing interval.
Open tool → - 3
Cycle if needed
No formal cycling required; effects appear to require continuous dosing and reverse within 4 weeks of cessation
Open tool → - 4
Monitor for side effects
Watch for: mild GI upset; occasional skin rash; contact dermatitis (rare). Stop or reduce dose if tolerability breaks down.
Why this dose
Hericenones and erinacines stimulate NGF mRNA expression and NGF protein release in cultured neurons; secondary anti-inflammatory and remyelination-supportive activity in preclinical models.
The typical dose (1000 mg) reflects 500 mg to 3 g/day depending on product form; trial-effective whole-powder doses are 3 g/day. Individual response varies with body weight, baseline status, concurrent training, and concurrent medications, so the labeled range is the starting point rather than the prescription.
How to administer
Lion's Mane is administered via the oral route. Oral dosing is straightforward: take with water, with or without food unless specifically noted.
Onset of action runs around 1 weeks after administration. Peak effect lands near 8 weeks post-dose. Plan the administration window so that peak effect lines up with whatever outcome you are dosing for, whether that is training, sleep, or symptom coverage.
Half-life note: Bioactive compound pharmacokinetics in humans are essentially unstudied
Cycling and tolerance
No formal cycling required; effects appear to require continuous dosing and reverse within 4 weeks of cessation
Effects to expect at typical dose
- Edible medicinal mushroom containing NGF-stimulating hericenones and erinacines
- Mori 2009 trial (n=30) in mild cognitive impairment showed cognitive improvement at 3 g/day for 16 weeks, reversing 4 weeks after discontinuation
- Saitsu 2019 (n=31) in older adults reported MoCA improvements at 3.2 g/day over 12 weeks
- Multiple small mood trials suggest reduced anxiety and depression scores at 1 to 4 g/day extract
- Mechanistic case rests on NGF stimulation and remyelination support; in vivo human NGF measurement is absent
- Product quality varies substantially; mycelium-on-grain products can be over 50% grain by weight
Best-graded outcomes
- B NGF stimulation in vitro : Replicated NGF mRNA and protein induction (Cultured neurons and astrocytes).
- B Remyelination and neuroprotection (preclinical) : Preclinical evidence in EAE and stroke models (Rodent demyelination and stroke models).
- B Long-term safety : Strong food-history safety record; no documented serious adverse signal (Centuries of food use).
Side effects and interactions
Common side effects
- mild GI upset
- occasional skin rash
- contact dermatitis (rare)
Notable interactions
- anticoagulants (minor): theoretical antiplatelet effect, no documented clinical events
Lists above cover commonly reported and well-characterized items. They are not exhaustive: review the full Lion's Mane profile and discuss with a clinician familiar with your medication list before starting, particularly if you are on prescription therapy or have a chronic condition.
Regulatory snapshot
- WADA status
- allowed
- DEA / Rx
- OTC supplement and food
- Pregnancy
- Insufficient data for routine supplementation; consumed historically as food without documented harm
- Legal status
- Dietary supplement and food worldwide; unscheduled and unrestricted
Do not use if
- mushroom allergy
Related calculators
Related research